Answers are grounded in this paper and cite their sources.
Case report demonstrates the diagnostic and therapeutic utility of nuclear medicine in high-risk pediatric neuroblastoma, highlighting multidisciplinary management.
Neuroblastoma is childhood’s most common extracranial solid tumor, with a broad spectrum of biological conduct. The high-risk disease encompasses a significant portion of childhood cancer mortality. Nuclear medicine methods, including disease risk categorization, are essential in the diagnostic process. However, nuclear medicine has its place as a segment of the multidisciplinary treatment of high-risk diseases, too. In this article, a patient diagnosed with high-risk neuroblastoma due to age and metastases is presented, with an accent on the role of nuclear medicine and a multidisciplinary approach in diagnostic and therapeutic procedures.
No takes yet. Share an insight, caveat, or question.
Nenadić et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: